معرفی
Brad Walsh is an Adjunct Professor at the School of Natural Sciences, Macquarie University with a focus on Proteomics, Cancer Research, and Biomedical Imaging. He has led projects in Glioblastoma, Prostate Cancer, and Nanotechnology-based diagnostics, including the development of the MiCheck® Prostate test and glypican-1 targeting antibodies.
- Key Research Areas: Proteomics, Cancer Biomarkers, Drug Delivery Systems, Glioblastoma, Prostate Cancer, Extracellular Vesicles
- Collaborations: ARC Training Centre for Biomedical Imaging Technology, NHMRC prostate cancer imaging grants
Recent Publications highlight advancements in Glypican-1 targeting immuno-PET agents for glioblastoma, proteomic biomarkers for prostate cancer, and nanotechnology applications for pancreatic cancer diagnostics.
Projects include:
- ARC Training Centre for Innovation in Biomedical Imaging Technology (2017–2023)
- ARC Research Hub for Integrated Device for End-user Analysis at Low-levels (2017–2023)
- Novel Prostate Cancer Target for Diagnosis (NHMRC, 2015–2018)
- Rapid Detection of Rare-Event Cells (2013–2016)
- Proteomic Study of Urine for Prostate Cancer Biomarkers (2011–2013)
۰مقاله منتشرشده
